Please note: Medicare Rebate for this test is subject to conditions. Patients may receive an invoice. 

Non-Small Cell Lung Carcinoma (NSCLC) EGFR Idylla Test 

Gene: EGFR

• Medicare (Fully covered) - MBS 73337 - EGFR gene status for access to an EGFR TKI or Pembrolizumab 
• Medicare (Fully covered) - MBS 73351 - NSCLC (Stage IIIB or IV), new sample following progression after treatment with an EGFR tyrosine kinase inhibitor. To determine EGFR T790M status for access to Osimertinib
• Non-Medicare eligible - $397.35

For non-Medicare eligible patients - Patient Financial Consent Form must be completed.

Fee above is an indication only; please contact testing laboratory for up-to date cost. 

Please refer to Molecular Genetics - Austin Pathology for specific testing details and request form for ordering, indicating the test required and the biopsy number and date of collection of the sample you wish to be tested.

After this form has been completed, please forward it to the Anatomical Pathology laboratory via the fax number found on the request form.

• At least 10% tumour nuclei
  
  
• 5μm sections on uncoated slides - 3 sections for resection specimens OR
• 5 sections for small biopsies or resections with very focal tumour OR
• FFPE tissue block 
  
  
• Copy of the histology or cytology report

Contact Molecular Diagnostics - Genetics on 03 9496 5657 to confirm add on suitability